The biotechnology research and experimental development sector in the UK has seen substantial growth over the years, with production value steadily increasing from 2013 to 2023. The sector faced significant fluctuations; for example, a slight dip of over 41% in 2014 followed by a sharp rise of nearly 161% in 2015. The growth momentum continued with some fluctuations, such as a moderate dip of around 11% in 2020, but bounced back with a notable 34% increase in 2021. As of 2023, the production value stood at 3040 million Euros, indicating a year-on-year growth of over 5% and a CAGR of 5.18% over the past five years.
Looking ahead, the production value is forecasted to reach 3850 million Euros by 2028, growing at an average annual rate (CAGR) of 3.66%. This indicates a continued upward trend, albeit at a slower growth rate compared to previous years. The 2028 forecast suggests a cumulative growth of nearly 20% from 2023 levels.
Future trends to watch for include advancements in gene editing technologies, personalized medicine, and biopharmaceutical developments. Investments in R&D, government policies, and international collaborations could further accelerate growth and innovations in the biotechnology sector.
